Needham & Company LLC Reaffirms "Buy" Rating for Immunocore (NASDAQ:IMCR)
Needham & Company LLC restated their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report issued on Friday, Benzinga reports. Needham & Company LLC currently has a $81.00 price target on the stock. IMCR has been the topic of several other research reports. SVB Leerink assumed coverage on shares of Immunocore […]